We are driven by a singular mission: to help patients with chronic diseases by leveraging AI to bridge the gap between symptoms and solutions.

Founded in 2014 by Dr. David C. Whitcomb and Jessica Gibson, this Pittsburgh-based biotechnology company is dedicated to transforming chronic disease care and research. Our innovative approach focuses on diagnosing and developing new treatments for complex diseases with high unmet need.